HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.

Abstract
The activity of human liver fumarylacetoacetate fumarylhydrolase (EC 3.7.1.2) has been determined with fumarylacetoacetate as substrate. The Km was found to be 1.3 mu mol/l. Subcellular fractionation showed localization of the enzyme in the particle-free supernatant (cytosol). ZnCl2, CuCl2 and p-chloromercuribenzoic acid had a marked inhibitory effect on the enzyme activity, but no inhibition was observed with a number of anions and substrate analogs. Fumarylacetoacetate fumarylhydorlase activity in liver tissue from a patient with hereditary tyrosinemia was found to be less 2% of the controls. The assay is applicable to 3 mg of liver tissue which may be obtained by needle biopsy.
AuthorsE A Kvittingen, E Jellum, O Stokke
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 115 Issue 3 Pg. 311-9 (Sep 1981) ISSN: 0009-8981 [Print] Netherlands
PMID7296877 (Publication Type: Journal Article)
Chemical References
  • Acetoacetates
  • Fumarates
  • Tyrosine
  • Hydrolases
  • fumarylacetoacetase
Topics
  • Acetoacetates (analysis, deficiency)
  • Adult
  • Aged
  • Amino Acid Metabolism, Inborn Errors (enzymology)
  • Cell Fractionation
  • Cytosol (enzymology)
  • Drug Stability
  • Fumarates (analysis, deficiency)
  • Humans
  • Hydrolases (analysis, deficiency)
  • Infant
  • Kinetics
  • Liver (enzymology)
  • Middle Aged
  • Tyrosine (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: